New Study Compares Treatment Options For Pre-Cancerous Condition Of Esophagus

... BÂRRX Medical, Inc. today announced the initiation of a landmark human study titled "Ablation of Intestinal Metaplasia Containing Dysplasia: a Multi-Center, Randomized, Sham-Controlled Trial." The AIM Dysplasia Trial will compare the effectiveness of the HALO360 System against the current standard of care for Barrett''s esophagus, which includes regular endoscopic biopsy surveillance and appropriate medical management of associated acid reflux disease (also called GERD)... click link for more info. ...